Articles

Gemtuzumab ozogamicin in children with relapsed or refractory acute myeloid leukemia: a report by Berlin-Frankfurt-Münster study group

Department of Pediatric Hematology and Oncology, University Hospital Essen, Germany
Department of Pediatric Hematology and Oncology, University Hospital Essen, Germany
Department of Pediatric Hematology and Oncology, Hannover Medical School, Germany
Department of Pediatrics, Jena University Hospital, Germany
Department of Pediatric Hematology and Oncology, Eppendorf University Hospital, Hamburg, Germany
Division of Pediatric Hematology/Oncology, University Children’s Hospital Zurich, Switzerland
St. Anna Children’s Hospital and Children’s Cancer Research Institute, Department of Pediatrics, Medical University of Vienna, Austria
Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
University Children’s Hospital Münster, Pediatric Hematology and Oncology, Germany
Department of Pediatric Hematology and Oncology, Hannover Medical School, Germany
Department of Pediatric Hematology and Oncology, University Hospital Essen, Germany
Department of Pediatric Hematology and Oncology, University Hospital Essen, Germany
Vol. 104 No. 1 (2019): January, 2019 https://doi.org/10.3324/haematol.2018.191841